Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2016-09-01
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Two trained SC ambassadors (student helpers) and one supervisor (experienced research assistant) will be deployed for each session of intervention at a SH. Potential subjects will be approached using the "a-foot-into-the-door" method in which SC ambassador will ask if smoker would like to reduce/quit smoking and receive SC intervention or advices. Smokers will be assessed for eligibility and informed written consent will be sought. Subjects will complete a brief self-administered questionnaire (baseline) using tablet. To reduce later hang-ups of telephone interventions or surveys, SC ambassador will save contact number of the trial into subjects' mobile phones.
Discussion: The findings will provide much needed and original evidence to support a main RCT on these new, proactive, simple and low-cost interventions for improving current SC services and policy for smokers who do not actively seek help from SC services in Hong Kong and elsewhere.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivating Smokers at Outdoor Public Smoking Hotspots to Have Quit Attempt With Nicotine Replacement Therapy Sampling
NCT02491086
Use of Nicotine Replacement Therapy (NRT) Sample and Brief Smoking Cessation Advice for Recruiting Smokers
NCT03717051
Nicotine Replacement Provided at a Tertiary Care Hospital
NCT01614054
Brief Tobacco Cessation Intervention
NCT02494960
Smoking Cessation in Cancer Patients
NCT01685723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nicotine Replacement Therapy
This experimental group receives health warning leaflet, 1-week free nicotine replacement therapy (gum/patch), a card containing instruction and potential side effects and follow-up intervention if they have the above side effects at 3-, 7- and 10-days.
Nicotine Replacement Therapy (NRT)
1-week free NRT (gum/patch) plus a card containing instruction and potential side effects.
Health warning leaflet
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Minimal Cessation Advice & Nicotine Replacement Therapy
This experimental group receives brief smoking cessation advice using AWARD model with a health warning leaflet, 1-week free nicotine replacement therapy (gum/patch), a card containing instruction and potential side effects and follow-up intervention if they have the above side effects at 3-, 7- and 10-days.
Nicotine Replacement Therapy (NRT)
1-week free NRT (gum/patch) plus a card containing instruction and potential side effects.
Minimal Cessation Advice (MCA)
Brief smoking cessation advice using AWARD model. AWARD: (1) Ask smoking habit; (2) Warn about smoking risk; (3) Advice to quit as soon as possible; (4) Refer to smoking cessation service; and (5) Do-it-again: if relapse/fail.
Health warning leaflet
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Minimal Cessation Advice
This experimental group receives brief smoking cessation advice using AWARD model with a health warning leaflet.
Minimal Cessation Advice (MCA)
Brief smoking cessation advice using AWARD model. AWARD: (1) Ask smoking habit; (2) Warn about smoking risk; (3) Advice to quit as soon as possible; (4) Refer to smoking cessation service; and (5) Do-it-again: if relapse/fail.
Health warning leaflet
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Control
This control group receives a health warning leaflet.
Health warning leaflet
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine Replacement Therapy (NRT)
1-week free NRT (gum/patch) plus a card containing instruction and potential side effects.
Minimal Cessation Advice (MCA)
Brief smoking cessation advice using AWARD model. AWARD: (1) Ask smoking habit; (2) Warn about smoking risk; (3) Advice to quit as soon as possible; (4) Refer to smoking cessation service; and (5) Do-it-again: if relapse/fail.
Health warning leaflet
An A4 double-side color leaflet containing shocking pictures of diseases associated with smoking.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Exhaled carbon monoxide (CO) level of 4ppm or above.
* Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua)
Exclusion Criteria
* Smokers who have psychiatric/psychological diseases or regular psychotropic medications
* Smokers who are using SC medication, NRT, other SC services or projects.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Wang Man-Ping
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Man Ping WANG
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PMCANp_2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.